The high prevalence of 'soft' bipolar (II) features in atypical depression

Comprehensive Psychiatry

Volumn 39, Issue 2, 1998, Pages 63-71

  Perugi, G ^a   Akiskal, H S ^b   Lattanzi, L ^b   Cecconi, D ^b   Mastrocinque, C ^b   Patronelli, A ^b   Vignoli, S ^b   Bemi, E ^b  

^a UNIVERSITY OF PISA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; DEPRESSION; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE DURATION; ELECTROCONVULSIVE THERAPY; ENZYME INHIBITION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIC DEPRESSIVE PSYCHOSIS; ONSET AGE; PERSONALITY DISORDER; PHOBIA; PREVALENCE;

EID: 0031941615     PISSN: 0010440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0010-440X(98)90080-3     Document Type: Article

References (56)

1. Sargant W. Drugs in the treatment of depression. BMJ 1961;1:225-227.
2. West ED, Dally PJ. Effect of iproniazid in depressive syndromes. BMJ 1959;1:1491-1494.
3. Davidson JRT, Miller RD, Turnbull CD, Sullivan JL. Atypical depression. Arch Gen Psychiatry 1982;39:527-534.
4. Klein DF, Davis J. Diagnosis and Drug Treatment of Psychiatric Disorders. Ed. 1. Baltimore, MD: Williams & Wilkins, 1968.
5. Liebowitz MR, Klein DF. Hysteroid dysphoria. Psychiatr Clin North Am 1979;2:555-575.
6. Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison W, Rabkin J, et al. Phenelzine vs imipramine in atypical depression: a preliminary report. Arch Gen Psychiatry 1984;41:669-677.
7. Liebowitz MR, Quitkin FM, Stewart JW, McGrath PJ, Harrison WM, Markowiz JS, et al. Antidepressant specificity in atypical depression. Arch Gen Psychiatry 1988;45:129-137.
8. Quitkin FM, Stewart JW, McGrath PJ, Liebowitz MR, Harrison WM, Tricamo E, et al. Phenelzine versus imipramine in the treatment of probable atypical depression: defining syndrome boundaries of selective MAOI responders. Am J Psychiatry 1988:145:306-311.
9. Quitkin FM, McGrath PJ, Stewart JW, Harrison WM, Tricamo E, Wager SG, et al. Atypical depression, panic attacks, and response to imipramine and phenelzine: a replication. Arch Gen Psychiatry 1990;47:935-941.
10. Dunner DL, Gershon ES, Goodwin FK. Heritable factors in the severity of affective illness. Biol Psychiatry 1976;11:31-42.
11. Akiskal HS, Khani MK, Scott-Strauss A. Cyclothymic temperamental disorders. Psychiatr Clin North Am 1979;2:527-554.
12. Akiskal HS. Mood disorders: clinical features. In: Kaplan HI, Sadock BJ (eds): Comprehensive Textbook of Psychiatry. Ed. 6. Vol. 1. Baltimore, MD: Williams & Wilkins, 1995:1123-1152.
13. Himmelhoch JM, Thase ME. The vagaries of the concept of atypical depression. In: Howells JG (ed): Modern Perspectives in the Psychiatry of the Affective Disorders. New York, NY: Plenum, 1989:223-242.
14. Himmeloch JM, Thase ME, Mallinger AG, Houck P. Tranylcypromine versus imipramine in anergic bipolar depression. Am J Psychiatry 1991:48:910-916.
15. Sovner RD. The clinical characteristics and treatment of atypical depression. J Clin Psychiatry 1981;42/7:285-289.
16. Thase ME. Atypical depressions. In: Flach F (ed): Diagnostics and Psychopathology. New York, NY: Norton, 1987:83-96.
17. Paykel ES, Rowan PR, Parker RR, Bhat AV. Response to phenelzine and amitriptyline in subtypes of outpatient depression. Arch Gen Psychiatry 1982;39:1041-1049.
18. Ravaris CL, Robinson DS, Ives JO, Nies A, Bartlett D. Phenelzine and amitriptyline in the treatment of depression: a comparison of present and past studies. Arch Gen Psychiatry 1980;37:1075-1080.
19. Quitkin FM. Poids des facteurs de personnalité dans la depression. Encephale 1993;19:491-492.
20. Lonnqvist J, Sihvo S, Syvalahti E, Kivirusu O. Moclobemide and fluoxetine in atypical depression a double-blind trial. J Affective Disord 1994;32:169-177.
21. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. DSM-IV. Washington, DC: American Psychiatric Press, 1994.
22. Paykel ES, Parker RR, Rowan PR, Rao BM, Taylor CN. Nosology of atypical depression. Psychol Med 1983;13:131-139.
23. Horwath E, Johnson J, Weissman MM, Hornig CD. The validity of major depression with atypical features based on a community study. J Affective Disord 1992;26:117-126.
24. Stewart JW, McGrath PJ, Rabkin JG, Quitkin FM. Atypical depression. A valid clinical entity? Psychiatr Clin North Am 1993;16:479-495.
25. Spitzer RL, Williams JBW, Gibbon M, First MB. Structured Clinical Interview for DSM-III-R (SCID-P). Washington, DC: American Psychiatric Press, 1990.
26. Cassano GB, Musetti L, Perugi G, Soriani A, Mignani V, McNair DM, et al. A proposed new approach to the clinical subclassification of depression illness. Pharmacopsychiatry 1988; 21:19-23.
27. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. DSM-III-R. Washington, DC: American Psychiatric Press, 1987.
28. Andreasen NC, Endicott J, Spitzer RL, Winokur G. The family history method using diagnostic criteria: reliability and validity. Arch Gen Psychiatry 1977;34:229-235.
29. Akiskal HS, Mallya G. Criteria for the "soft" bipolar spectrum: treatment implications. Psychopharmacol Bull 1987; 23:68-73.
30. Schneider K. Psychopathic Personalities (Hamilton MW, translator). London, UK: Cassell, 1958.
31. Akiskal HS, Akiskal K. Cyclothymic, hyperthymic and depressive temperaments as subaffective variants of mood disorders. In: Tasman A, Riba MB (eds): APA Review. Washington, DC: American Psychiatric Press, 1992:43-62.
32. Cassano GB, Akiskal HS, Musetti L, Perugi G, Soriani A, Mignani V. Psychopathology, temperament and past course in primary major depressions. II. Toward a redefinition of bipolarity with a new semistructured interview for depression. Psychopathology 1989;22:278-288.
33. Perugi G, Musetti L, Simonini E, Piagentini F, Cassano GB, Akiskal HS. Gender-mediated clinical features of depressive illness. The importance of temperamental differences. Br J Psychiatry 1990;157:835-841.
34. Cassano GB, Akiskal HS, Savino M, Musetti L, Perugi G. Proposed subtypes of bipolar II and related disorders: with hypomanic episodes (or cyclothymia) and with hyperthymic temperament. J Affective Disord 1992;26:127-140.
35. Perugi G, Akiskal HS, Micheli C, Musetti L, Paiano A, Quilici C. Clinical subtypes of bipolar mixed states: validating a broader European definition in 143 cases. J Affective Disord 1997;43:169-180.
36. Akiskal HS, Djenderedjian AM, Rosenthal RH, Khani MK. Cyclothymic disorder: validating criteria for inclusion in the bipolar affective group. Am J Psychiatry 1977;134:1227-1233.
37. Feighner G, Robins E, Guze SB, Wosdruff RA, Winokur G, Munoz R. Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 1972;26:57-63.
38. Manning JS, Haykal RF, Connor PD, Akiskal HS. On the nature of depressive and anxious states in a family practice setting: the high prevalence of bipolar II and related disorders in a cohort followed longitudinally. Compr Psychiatry 1997;38:102-108.
39. Perugi G, Giannotti D, DiVaio S, Frare F, Saettoni M, Cassano GB. Fluvoxamine in the treatment of body dysmorphic disorder (dysmorphophobia). Int Clin Psychopharmacol 1996;11: 247-254.
40. Spitzer RL, Williams JBW, Gibbon M, First MB. Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-II). Washington, DC: American Psychiatric Press, 1990.
41. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 1967;6:278-296.
42. Rosenthal NE, Heffernan MM, Bulimia, carbohydrate craving, and depression. A central connection? In: Wurtman RJ (ed): Nutrition and the Brain. Vol. 7. New York, NY: Raven, 1986:139-166.
43. Derogatis LR, Lipman RS, Covi L. The SCL-90: an outpatient psychiatric rating scale. Psychopharmacol Bull 1973; 9:13-28.
44. Akiskal HS. The prevalent clinical spectrum of bipolar disorders: beyond DSM-IV. J Clin Psychopharmacol 1996; 16(Suppl):4S-14S.
45. McGrath PJ, Stewart JW, Harrison WM, Ocepek-Welikson K, Rabkin JG, Nunes EN, et al. The predictive value of symptoms of atypical depression for differential drug treatment outcome. J Clin Psychopharmacol 1992;12:197-202.
46. Stewart JW, Tricamo E, McGrath PJ, Quitkin FM. Prophylactic efficacy of phenelzine and imipramine in chronic atypical depression: likelihood of recurrence on discontinuation after 6 months' remission. Am J Psychiatry 1997;154:31-36.
47. Robertson HA, Lam RW, Stewart JN, Yatham LN, Tam EM, Zis AP. Atypical depressive symptoms and clusters in unipolar and bipolar depression. Acta Psychiatr Scand 1996;94: 421-427.
48. Dunner DL, Kai Tay L. Diagnostic reliability of the history of hypomania in bipolar II patients and patients with major depression. Compr Psychiatry 1993;34:303-307.
49. Bougeois M, Hantouche E, Akiskal HS. Clinical subtypes of bipolar disorder in a French multi-center study. Eur Neuropsychopharmacol 1996;6(Suppl3):219.
50. Perugi G, Musetti L, Pezzica P, Piagentini F, Cassano GB, Akiskal HS. Suicide attempts in primary major depressive subtypes. Psychiatr Fenn 1989;19:95-102.
51. Stone M. Contemporary shift of the borderline concept from a sub-schizophrenic disorder to a subaffective disorder. Psychiatr Clin North Am 1979;2:577-594.
52. Akiskal HS. Subaffective disorders: dysthymic, cyclothymic and bipolar II disorders in the "borderline" realm. Psychiatr Clin North Am 1981;4:25-46.
53. Akiskal HS, Chen SE, Davis GC, Puzantian VR, Kashgarian M, Bolinger JM. Borderline: an adjective in search of a noun. J Clin Psychiatry 1985;46:41-48.
54. Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, Keller M, et al. Switching from 'unipolar' to bipolar II. An 11 year prospective study of clinical and temperamental predictors in 559 patients. Arch Gen Psychiatry 1995;52:114-123.
55. Gunderson JG, Elliot GR. The interface between borderline personality disorder and affective disorder. Am J Psychiatry 1985;142:277-288.
56. Gunderson JG, Phillips KA. A current view of the interface between borderline personality disorder and depression. Am J Psychiatry 1991;148:967-975.